Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,468 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.
Lambertini M, Kroman N, Ameye L, Cordoba O, Pinto A, Benedetti G, Jensen MB, Gelber S, Del Grande M, Ignatiadis M, de Azambuja E, Paesmans M, Peccatori FA, Azim HA Jr. Lambertini M, et al. Among authors: pinto a. J Natl Cancer Inst. 2018 Apr 1;110(4):426-429. doi: 10.1093/jnci/djx206. J Natl Cancer Inst. 2018. PMID: 29087485 Free PMC article.
An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer.
Sánchez-Navarro I, Gámez-Pozo A, Pinto A, Hardisson D, Madero R, López R, San José B, Zamora P, Redondo A, Feliu J, Cejas P, González Barón M, Angel Fresno Vara J, Espinosa E. Sánchez-Navarro I, et al. Among authors: pinto a. BMC Cancer. 2010 Jun 28;10:336. doi: 10.1186/1471-2407-10-336. BMC Cancer. 2010. PMID: 20584321 Free PMC article.
Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.
Azim HA Jr, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, De Mattos-Arruda L, Pistilli B, Pinto A, Jensen MB, Cordoba O, de Azambuja E, Goldhirsch A, Piccart MJ, Peccatori FA. Azim HA Jr, et al. Among authors: pinto a. J Clin Oncol. 2013 Jan 1;31(1):73-9. doi: 10.1200/JCO.2012.44.2285. Epub 2012 Nov 19. J Clin Oncol. 2013. PMID: 23169515 Free PMC article.
Prognostic value of neutrophil-to-lymphocyte ratio in advanced cancer patients receiving immunotherapy.
Viñal D, Gutierrez-Sainz L, Martinez D, Garcia-Cuesta JA, Pedregosa J, Villamayor J, Ostios L, Sanchez-Cabrero D, Higuera O, Pinto A, Rodriguez-Salas N, Espinosa E, de Castro J, Feliu J. Viñal D, et al. Among authors: pinto a. Clin Transl Oncol. 2021 Jun;23(6):1185-1192. doi: 10.1007/s12094-020-02509-1. Epub 2020 Nov 23. Clin Transl Oncol. 2021. PMID: 33226553
The present and future of gene profiling in breast cancer.
Espinosa E, Gámez-Pozo A, Sánchez-Navarro I, Pinto A, Castañeda CA, Ciruelos E, Feliu J, Vara JA. Espinosa E, et al. Among authors: pinto a. Cancer Metastasis Rev. 2012 Jun;31(1-2):41-6. doi: 10.1007/s10555-011-9327-7. Cancer Metastasis Rev. 2012. PMID: 22124734 Review.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel.
Mendiola M, Martínez-Marin V, Herranz J, Heredia V, Yébenes L, Zamora P, Castelo B, Pinto Á, Miguel M, Díaz E, Gámez A, Fresno JÁ, Ramírez de Molina A, Hardisson D, Espinosa E, Redondo A. Mendiola M, et al. Among authors: pinto a. Oncotarget. 2016 Apr 26;7(17):24217-27. doi: 10.18632/oncotarget.8128. Oncotarget. 2016. PMID: 26992213 Free PMC article.
Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO).
Puente J, González-Del-Alba A, Sala-Gonzalez N, Méndez-Vidal MJ, Pinto A, Rodríguez Á, Cuevas Sanz JM, Muñoz Del Toro JR, Useros Rodríguez E, García García-Porrero Á, Vázquez S. Puente J, et al. Among authors: pinto a. BMC Cancer. 2019 Aug 5;19(1):766. doi: 10.1186/s12885-019-5974-9. BMC Cancer. 2019. PMID: 31382926 Free PMC article.
4,468 results